Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | -0.35% | -0.35% | -49.64% |
04-30 | Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-49.64% | 186M | D+ | ||
-14.68% | 18.88B | A | ||
-42.33% | 2.84B | C+ | ||
+17.00% | 1.85B | - | - | |
-0.51% | 1.66B | - | ||
+27.15% | 1.26B | B+ | ||
-13.90% | 989M | - | ||
-21.76% | 896M | - | C- | |
-2.72% | 757M | - | ||
-23.95% | 633M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MASS Stock
- Ratings 908 Devices Inc.